Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Neurosurgery
•
Neurology
•
Tumor Neurosurgery
For patients with hydrocephalus secondary to leptomeningeal disease, how do you determine what type of shunt device to place?
Related Questions
How do you determine the timeline for healing after craniotomy prior to starting chemotherapy and radiation?
Under what circumstances would you start steroids for a patient with a new brain tumor prior to biopsy or resection?
How do you determine timing for surveillance imaging for an asymptomatic patient who was incidentally found to have a meningioma?
Under what circumstances would you consider the utilization of a supraorbital approach through an eyebrow incision?
For a patient with large volume glioblastoma, what do you do if they are found to have a subdural infection in the middle of chemoRT requiring repeat surgery?
How long would you stop standard GBM radiotherapy if the patient had a fall with minor head trauma?
For a patient with glioblastoma also found to have a distant presumed meningioma with a location/size such that you would have otherwise recommended RT, would you offer concurrent treatment?
How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?
How do you conduct follow up on patients with brain mets who have undergone GammaTile placement?
How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?
